We report an 80-year-old male with a nodular fibrous pseudotumor (NFP), a rare benign tumor typically linked to trauma, surgery, or inflammation. Unusually, it presented as a mobile peritoneal loose body (PLB) despite no relevant abdominal history. Imaging showed a well-defined oval mass (70 × 63 mm). Pathological examination confirmed NFP, showing hyalinized collagen and fibroblast proliferation without atypia. This is the first NFP presenting as a PLB at our institution. The patient underwent successful laparoscopic resection with no recurrence during follow-up. This case highlights that: NFP can mimic mobile intraperitoneal lesions, requiring distinction from malignancy; pathological confirmation is essential due to overlapping computed tomography features with metastases; and the PLB presentation expands the known etiological spectrum beyond classical triggers. NFP should be considered in the differential diagnosis of peritoneal nodules, especially in atypical scenarios.
Background and objective: MicroRNAs (miRNAs) are implicated in cancer by exerting roles in tumor growth, metastasis, and even drug resistance. The general trends of miRNA research in diverse cancers are not fully understood. In this work, miRNA-related research in colorectal cancer, prostate cancer, leukemia, and brain tumors was analyzed in search of key research trends with clinical potential.Methods: A bibliometric analysis of articles, spanning from 2014 to 2024, was carried out with the major focus laid on four types of cancers. The Co-citation network analysis, keyword bursts, and the collaborative pattern were done in VOSviewer and CiteSpace, respectively.Results: Colorectal cancer had the highest publication volume, with research primarily focusing on gene expression, extracellular vesicles, and non-coding RNAs. Prostate cancer showed a shift toward clinical applications, while leukemia and brain tumor research, though less extensive, highlighted miRNA’s potential in early diagnosis and treatment. Co-citation analysis identified emerging research collaborations and key contributors.Conclusion: miRNA plays a pivotal role in cancer diagnosis, biomarker development, and therapeutic interventions. With advancements in non-invasive diagnostics and personalized medicine, miRNA offers significant potential for clinical applications. Future research should focus on miRNA’s role in drug resistance and combination therapies to accelerate its clinical translation.